Delivery Order SPE2DB20D1004-SPE2DB23FG4D3

Award Date 8/21/23
Potential Completion Date 8/22/23
Potential Value $3.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,810.23, is a firm fixed-price delivery order for the supply of pioglitazone HCL 30 mg tablets. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,222.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a broader Indefinite Delivery Contract (IDC) with the DLA, is for the supply of 4566832860 Pioglitazone HCL 30 mg tablets. The IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,719.81 firm fixed-price delivery order is for the supply of PIOGLITAZONE HCL 45 MG TABLET 30S. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,691.69 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,056.91, covers the provision of 4566474890 ! PIOGLITAZONE HCL 15 MG TABLET 30S, a pharmaceutical product. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award with ID SPE2DB20D3103 and SPE2DB24FM6R4 was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,720.29, is a Firm Fixed Price Delivery Order for the supply of 4563651894 - Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 14, 2024 and was awarded on February 13, 2024. The place of performance is Conshohocken, PA. This award is associated with a larger...
This federal contract award, identified as SPE2DB22D1041|SPE2DB24FTZJ2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $6,221.93 fixed-price delivery order is for the provision of 4563400435 - PIOGLITAZONE HCL 30 MG TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the awardee....
This federal contract award, valued at $3,675.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, to provide GLIPIZIDE ER 10 MG TABLET 1000S to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is a Delivery Order valued at $8,372.91 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4566904877 - DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product used for diabetes management. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,073.81, is a Delivery Order for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG4D3
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,074.90, is for the delivery of Pioglitazone HCL 45 mg tablets.

The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition.

This award demonstrates Amerisourcebergen's significant role as a critical supplier of essential pharmaceutical and medical commodities to the U.S. federal government, particularly the Department of Defense and Department of Veterans Affairs healthcare systems.

Generated 2/27/25, 12:45 PM